Do EU5 Countries With Favourable Healthcare Expenditure and Reimbursement Indicators Have Better Patient-Reported Access to Treatments for Rare Diseases?

Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.071
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search